Target intelligence / Profile preview

Phosphoglucomutase-like protein 5 (PGM5)

Target
PGM5
Molecular classification
Enzyme superfamily (alpha-D-phosphohexomutase family, but lacks enzymatic activity), Structural protein, Multi‐adaptor protein
01

Overview

Phosphoglucomutase-like protein 5 (PGM5), also referred to as aciculin, is a protein found primarily in muscle tissue where it functions as a dynamic structural multi-adaptor involved in myofibril organization and maintenance[2]. PGM5 interacts with key muscle proteins such as Filamin C (FLNc) and Xin actin-binding proteins, localizing to critical muscle cell structures including intercalated discs, myotendinous junctions, and Z-discs[2]. Unlike its close homolog phosphoglucomutase 1 (PGM1), PGM5 does not exhibit enzymatic activity for phosphoglucomutase reactions, likely due to differences in active-site loops, but retains high structural similarity within the alpha-D-phosphohexomutase family[1]. Functional studies demonstrate that PGM5 is crucial for muscle development and remodeling, with loss-of-function experiments leading to severe myofibril defects in cell and animal models[2]. Currently, PGM5 is not recognized as a therapeutic target, and there are no known drugs targeting this protein[1][2][4].

Other names
aciculinPGMRPPGM5_HUMAN
02

Biological functions

Myofibril assembly and maintenanceMuscle cell architecture (assembly, alignment, membrane attachment, remodeling of myofibrils)Muscle repair (especially under stress)
03

Disease associations

Muscle developmental disorders (implicated by silencing in model organisms causing myofibril defects)Other (not a direct disease target; indirect effects may relate to muscle function)

Beyond the preview

Go deeper on Phosphoglucomutase-like protein 5 (PGM5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphoglucomutase-like protein 5 (PGM5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call